Veterinary Practices Can Expect Better Benchmarking with VetSuccess Report Aligned to AAHA/VMG Chart of Accounts

TORONTO, June 12, 2019 /PRNewswire/ — Veterinary practices in the US and Canada finally have an effortless way to align their revenue codes to the industry-endorsed AAHA/VMG Chart of Accounts, thanks to the new Practice Overview Report from VetSuccess.

With the report’s new revenue breakdown, practice managers and owners can benchmark where their dollars come from using an apples-to-apples comparison against other practices.

As of 2017, AAHA, AVMA, VHMA, and VetPartners all endorsed the AAHA/VMG Chart of Accounts as the industry standard for classifying revenue, expense, and balance sheet accounts in small animal veterinary practices.

For practices to align, they must classify every code in their practice management software to follow the AAHA/VMG Chart of Accounts. It’s speculated that the risk of altering historical data and the time involved to change codes is a hinderance to adoption of this industry endeavor.

With their proprietary mapping tool, VetSuccess will now automatically align practice revenue in the Practice Overview Report to the AAHA/VMG Chart of Accounts, regardless of how each practice has revenue coded in their practice management software.

Practices no longer need to spend weeks reclassifying every transaction code just to align with the AAHA/VMG Chart of Accounts.

“VetSuccess is proud to support this important industry initiative to standardize revenue data,” says VetSuccess CEO Martin Traub-Werner. “We’re thrilled to give veterinary practices an easy way to gain perspective and set reasonable performance expectations with benchmarks. The reclassification safely happens behind the scenes and does not change any codes in the practice management system.”

The Practice Overview Report appendix now includes a print-friendly revenue statement with revenue per patient benchmarks in each revenue category. According to Traub-Werner, this powerhouse report handles half the heavy lifting required to determine practice profitability.

To learn more about the Practice Overview Report, schedule a consultation at Vetsuccess.com/join/get-demo/.

About VetSuccess

VetSuccess (Vetsuccess.com) is a membership service specializing in the delivery of data-driven practice management solutions, including monthly practice performance reports, dashboards, and automated marketing solutions. Industry-leading analytics experts make sense of the data in practice management software and compile the most important metrics to help veterinary practices to be more efficient, more focused, and more successful.

Press contact:
Martin Traub-Werner, Founder and CEO
866-408-8554 
martin@vetsuccess.com

View original content:http://www.prnewswire.com/news-releases/veterinary-practices-can-expect-better-benchmarking-with-vetsuccess-report-aligned-to-aahavmg-chart-of-accounts-300865515.html

SOURCE VetSuccess

Staff

Recent Posts

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…

22 mins ago

Universal Recall Platform Alliance Launches to Keep Patients Safe

Industry initiative URPA broadens calls to improve speed, accuracy of recall communicationWEST HOLLYWOOD, CA /…

22 mins ago

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…

3 hours ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…

3 hours ago

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by…

3 hours ago

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading…

3 hours ago